Buy this Article for $7.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.


antiplatelet therapy, clopidogrel, clopidogrel resistance, cyclopentyl-triazolo-pyrimidine agents, CYP2C19 genetic variance, DAPT, dual antiplatelet therapy, oral antiplatelet comparison, oral antiplatelets, prasugrel, protease-activated receptor-1 antagonists, thienopyridines, ticagrelor, vorapaxar



  1. Jeffords, Travis BSN-RN, CCRN


Abstract: New and more potent oral antiplatelet agents have shown better clinical outcomes over the last few years. This article reviews the latest oral antiplatelet therapies available, their indications and contraindications, genetic resistance, and major drug interactions.